Protective effects of silymarin-loaded chitosan nanoparticles in the diet-induced hyperlipidemia rat model

Publish Year: 1403
نوع سند: مقاله ژورنالی
زبان: English
View: 37

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-27-6_008

تاریخ نمایه سازی: 28 اسفند 1402

Abstract:

Objective(s): Obesity is a metabolic syndrome that leads to many chronic diseases worldwide. In this study, we investigate the antihyperlipidemic activities of chitosan nanoparticles (CH NPs) on silymarin (SIL) as a carrier in the drug delivery system that can improve some biochemical parameters and hormones in the model of hyperlipidemic rats receiving a high-fat diet (HFD). Materials and Methods: Physicochemical characterization of silymarin-loaded chitosannanoparticles (CH-SIL NPs) was done by Fourier-transform infrared (FTIR) spectroscopy, dynamic light scattering (DLS), and drug loading efficiency (LE). Diet-induced hyperlipidemic rats were treated with SIL (۱۵ mg/kg/day) and CH-SIL NPs(۱۵ mg/kg/day) for twelve weeks orally daily. The body weight loss (BW), food consumption, serum total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), levels of fasting blood glucose (FBG) in serum, serum insulin, cortisol, testosterone, and brain neuropeptide Y (NPY), Y۱ and Y۵ receptor mRNA expression were analyzed. Results: A significant reduction in BW and food consumption from ۴۱۷ ± ۱۶ g and ۳۳ ± ۱.۰۳ in group HFD to ۳۳۸ ± ۱۰ g and ۱۷.۳۳ ± ۱.۰۲ in group CHS+HFD was observed, respectively. This data revealed that CH-SIL NPs improved hyperlipidemia, hyperinsulinemia, and hyperglycemia, reduced serum cortisol, and down-regulated NPY and Y۱R with a significant increase in HDL and testosterone hormones compared to the control group. Conclusion: The developed Sil-loaded CH NPs were good agents for improving efficacy. It is the first report of the proposed weight loss mechanism of SIL CH NPs, thereby providing information about the anti-hyperlipidemic and antihyperglycemic effects of silymarin-loaded chitosan nanoparticles, a natural food with proper effects against metabolic disorders in case of hyperlipidemia that may lead to obesity and up-regulation of brain NPY.

Authors

Vahid Akheratdoost

Department of Veterinary Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran

Negar Panahi

Department of Veterinary Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran

Shahabeddin Safi

Department of Veterinary Pathobiology, Science and Research Branch, Islamic Azad University, Tehran, Iran

Faraz Mojab

Department of Pharmacognosy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Ghasem Akbari

Department of Veterinary Clinical Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Vahabzadeh M, Amiri N, Karimi G. Effects of silymarin on ...
  • Vohra MS, Benchoula K, Serpell CJ, Hwa WE. AgRP/NPY and ...
  • Magdy Beshbishy A, Hetta HF, Hussein DE, Saati AA, C. ...
  • Collins K, Hart D, Seerattan R, Reimer R, Herzog W. ...
  • Bunner W, Landry T, Laing BT, Li P, Rao Z, ...
  • Yeung AY, Tadi P. Physiology, Obesity Neurohormonal Appetite and Satiety ...
  • Zhang L, Bijker MS, Herzog H. The neuropeptide Y system: ...
  • Tamura Y, Hayashi K, Omori N, Nishiura Y, Watanabe K, ...
  • Kołota A, Głąbska D. Dietary Intake of Milk Thistle Seeds ...
  • Feng B, Huang B, Jing Y, Shen S, Feng W, ...
  • Malihi F, Hosseini-Tabatabaei A, Esmaily H, Khorasani R, Baeeri M, ...
  • Colturato CP, Constantin RP, Maeda Jr AS, Constantin RP, Yamamoto ...
  • Javed S, Kohli K, Ali M. Reassessing bioavailability of silymarin. ...
  • Abdelaal M, Abdel‐Razik E, Abdel‐Bary E, El‐Sherbiny I. Chitosan‐based interpolymeric ...
  • Abdullah AS, Sayed IETE, El-Torgoman AMA, Kalam A, Wageh S, ...
  • Kamyabi R, Jahandideh A, Panahi N, Mohammadnejad S. Synergistic cytotoxicity ...
  • Abdel-Baky ES, Abdel-Rahman ON. Assessing the effects of orlistat as ...
  • Moghaddam AH, Sangdehi SRM, Ranjbar M, Hasantabar V. Preventive effect ...
  • Rashedi J, Haghjo AG, Abbasi MM, Tabrizi AD, Yaqoubi S, ...
  • Kubant R, Poon AN, Sanchez‐Hernandez D, Domenichiello AF, Huot PS, ...
  • Gumbs M, Eggels L, Kool T, Unmehopa U, Van den ...
  • Jiang Y, Dai M, Nie W-J, Yang X-R, Zeng X-C. ...
  • Behiry EG, El Nady NM, OM AH, Mattar MK, Magdy ...
  • Sánchez ML, Rodríguez FD, Coveñas R. Neuropeptide Y peptide family ...
  • Fazil M, Md S, Haque S, Kumar M, Baboota S, ...
  • Sharma A, Puri V, Kakkar V, Singh I. Formulation and ...
  • Abdelaal K, Attia KA, Niedbała G, Wojciechowski T, Hafez Y, ...
  • Alipour M, reza Bigdeli M, Aligholi H, Rasoulian B, Khaksarian ...
  • Priyadharsini RP. Animal models to evaluate anti‐atherosclerotic drugs. Fundam Clin ...
  • Liu C-Y, Chang T-C, Lin S-H, Wu S-T, Cha T-L, ...
  • Aladaileh SH, Saghir SA, Murugesu K, Sadikun A, Ahmad A, ...
  • Esmaeili V, Zendehdel M, Shahverdi A, Alizadeh A. Relationship between ...
  • Park C, Kim J, Ko S-B, Choi YK, Jeong H, ...
  • Shen L, Xiong Y, Wang DQ, Howles P, Basford JE, ...
  • Luo J, Qi J, Wang W, Luo Z, Liu L, ...
  • Badshah H, Ullah I, Kim SE, Kim T-h, Lee HY, ...
  • Choi E-J, Kim E-K, Jeoung NH, Kim S-H. Effect of ...
  • Sayin FK, Buyukbas S, Basarali MK, Alp H, Toy H, ...
  • Sobolová L, Škottová N, Večeřa R, Urbánek K. Effect of ...
  • Talbi A, Khelili K, Remita F, Abdennour C. The benefit ...
  • Thakare VN, Dhakane VD, Patel BM. Potential antidepressant-like activity of ...
  • نمایش کامل مراجع